Literature DB >> 19263258

Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence.

Ceryl A Harwood1, Christopher J McDermott, Pamela J Shaw.   

Abstract

Motor neuron disease (MND) is a devastating neurodegenerative condition associated with considerable disability and a poor prognosis. Despite improvements in symptomatic management in recent years, few therapies are available which modify survival. However, the challenge to find successful treatments would be greatly assisted by clearer elucidation of the underlying pathoaetiology. Many potential exogenous risk factors have been proposed as part of a gene-environment interaction in the aetiology of MND. A growing interest in the role of vigorous physical activity in the development of MND has followed reports of a higher than expected incidence of the disease in professional sports people. Such an association is also supported by current hypotheses concerning the cellular and genetic mechanisms of MND. However, evidence from epidemiological research remains conflicting and inconclusive. This article reviews the existing literature regarding physical activity as a risk factor for MND and the potential biological and genetic plausibility for this association.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19263258     DOI: 10.1080/17482960802549739

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  30 in total

1.  Strengthening the Case for Cluster Set Resistance Training in Aged and Clinical Settings: Emerging Evidence, Proposed Benefits and Suggestions.

Authors:  Christopher Latella; Carolyn Peddle-McIntyre; Lauren Marcotte; James Steele; Kristina Kendall; Ciaran M Fairman
Journal:  Sports Med       Date:  2021-05-13       Impact factor: 11.136

2.  Recumbent stepping aerobic exercise in amyotrophic lateral sclerosis: a pilot study.

Authors:  Anjali Sivaramakrishnan; Sangeetha Madhavan
Journal:  Neurol Sci       Date:  2019-02-04       Impact factor: 3.307

3.  Amyotrophic lateral sclerosis, physical exercise, trauma and sports: results of a population-based pilot case-control study.

Authors:  Ettore Beghi; Giancarlo Logroscino; Adriano Chiò; Orla Hardiman; Andrea Millul; Douglas Mitchell; Robert Swingler; Bryan J Traynor
Journal:  Amyotroph Lateral Scler       Date:  2010-05-03

Review 4.  Epidemiological evidence that physical activity is not a risk factor for ALS.

Authors:  Bello Hamidou; Philippe Couratier; Cyril Besançon; Marie Nicol; Pierre Marie Preux; Benoit Marin
Journal:  Eur J Epidemiol       Date:  2014-07-02       Impact factor: 8.082

5.  New insights on physical activity and amyotrophic lateral sclerosis.

Authors:  Alberto Ascherio; Eilis Joan O'Reilly
Journal:  Eur J Epidemiol       Date:  2016-03-08       Impact factor: 8.082

6.  Lockhart Clarke's contribution to the description of amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Michael Swash; George C Ebers
Journal:  Brain       Date:  2010-06-24       Impact factor: 13.501

7.  Participation in Physical Activity and Risk for Amyotrophic Lateral Sclerosis Mortality Among Postmenopausal Women.

Authors:  Yvonne L Eaglehouse; Evelyn O Talbott; Yuefang Chang; Lewis H Kuller
Journal:  JAMA Neurol       Date:  2016-03       Impact factor: 18.302

Review 8.  Aberrant regulation of DNA methylation in amyotrophic lateral sclerosis: a new target of disease mechanisms.

Authors:  Lee J Martin; Margaret Wong
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

9.  Occupational formaldehyde and amyotrophic lateral sclerosis.

Authors:  Ryan M Seals; Marianthi-Anna Kioumourtzoglou; Ole Gredal; Johnni Hansen; Marc G Weisskopf
Journal:  Eur J Epidemiol       Date:  2017-06-05       Impact factor: 8.082

10.  Downregulation of genes with a function in axon outgrowth and synapse formation in motor neurones of the VEGFdelta/delta mouse model of amyotrophic lateral sclerosis.

Authors:  Alice Brockington; Paul R Heath; Hazel Holden; Paul Kasher; Florian L P Bender; Filip Claes; Diether Lambrechts; Michael Sendtner; Peter Carmeliet; Pamela J Shaw
Journal:  BMC Genomics       Date:  2010-03-26       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.